"Idiopathic pulmonary fibrosis acute exacerbation" trang 1 - tải miễn phí từ tailieunhanh
Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: Impact on survival and acute exacerbation

Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: Impact on survival and acute exacerbation
8    43    1
Azithromycin for idiopathic acute exacerbation of idiopathic pulmonary fibrosis: A retrospective single-center study

Azithromycin for idiopathic acute exacerbation of idiopathic pulmonary fibrosis: A retrospective single-center study
8    37    1
Acute exacerbation of idiopathic pulmonary fibrosis induced by pertussis: The first case report

Acute exacerbation of idiopathic pulmonary fibrosis induced by pertussis: The first case report
4    57    1
Treatment of acute exacerbation of idiopathic pulmonary fibrosis with direct hemoperfusion using a polymyxin B-immobilized fiber column improves survival

Treatment of acute exacerbation of idiopathic pulmonary fibrosis with direct hemoperfusion using a polymyxin B-immobilized fiber column improves survival
11    37    1
The efficacy of recombinant human soluble thrombomodulin (rhsTM) treatment for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and metaanalysis

The efficacy of recombinant human soluble thrombomodulin (rhsTM) treatment for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and metaanalysis
12    39    1
Administration of nintedanib after discontinuation for acute exacerbation of idiopathic pulmonary fibrosis: A case report

Administration of nintedanib after discontinuation for acute exacerbation of idiopathic pulmonary fibrosis: A case report
4    50    1
Study protocol: Exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebocontrolled, multi-center phase III trial (EXAFIP)

Study protocol: Exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebocontrolled, multi-center phase III trial (EXAFIP)
8    42    1
Prognosis of patients with acute exacerbation of combined pulmonary fibrosis and emphysema: A retrospective single-centre study

Prognosis of patients with acute exacerbation of combined pulmonary fibrosis and emphysema: A retrospective single-centre study
7    35    1
Survival in Idiopathic pulmonary fibrosis acute exacerbations: The non-steroid approach

Survival in Idiopathic pulmonary fibrosis acute exacerbations: The non-steroid approach
9    58    1
Efficacy of concurrent treatments in idiopathic pulmonary fibrosis patients with a rapid progression of respiratory failure: An analysis of a national administrative database in Japan

Efficacy of concurrent treatments in idiopathic pulmonary fibrosis patients with a rapid progression of respiratory failure: An analysis of a national administrative database in Japan
9    15    1
Survival after repeated surgery for lung cancer with idiopathic pulmonary fibrosis: A retrospective study

Survival after repeated surgery for lung cancer with idiopathic pulmonary fibrosis: A retrospective study
9    25    1
Underlying and immediate causes of death in patients with idiopathic pulmonary fibrosis

Underlying and immediate causes of death in patients with idiopathic pulmonary fibrosis
10    22    1
Pneumothorax in patients with idiopathic pulmonary fibrosis: A real-world experience

Pneumothorax in patients with idiopathic pulmonary fibrosis: A real-world experience
6    21    1
The overexpression of peroxiredoxin-4 affects the progression of idiopathic pulmonary fibrosis

The overexpression of peroxiredoxin-4 affects the progression of idiopathic pulmonary fibrosis
12    28    1
Cluster analysis-based clinical phenotypes of idiopathic interstitial pneumonia: Associations with acute exacerbation and overall survival

Cluster analysis-based clinical phenotypes of idiopathic interstitial pneumonia: Associations with acute exacerbation and overall survival
9    31    1
Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: A population-based study

Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: A population-based study
10    26    1
Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: A retrospective real-world cohort study

Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: A retrospective real-world cohort study
13    20    1
Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease

Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease
8    46    1